Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P250028/S003

Synergy Disc

Synergy Spine Solutions, Inc. · Decision date Sep 17, 2026

FDA DECISIONP250028/S003

What did the FDA approve?

FDA records P250028/S003 as a supplement to PMA P250028, with the supplement type “Real-Time Process”. The recorded decision is approval, dated Sep 17, 2026.

FDA approval order statement

packaging materials changes and the addition of a secondary packaging configuration
Regulatory pathway
PMA supplement
Supplement type
Real-Time Process
Clinical specialty
Orthopedic
Decision date
Sep 17, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
P250028/S003
Regulatory pathway
PMA supplement
Product code
MJO
Decision code
APPR
Decision date
Sep 17, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Prosthesis, intervertebral disc.

Product code
MJO
FDA device class
3

For the original device and its historical approval scope, see PMA P250028. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P250028/S003 received

    Application receipt date recorded by FDA.

  2. P250028/S003 · FDA decision

    Real-Time Process

Timeline entries are records held by MedtechLedger for P250028. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P250028

Product / regulatory recordCompanyPathwayDecision dateSource
Synergy Spine Solutions, Inc.PMA approvalFeb 26, 2026FDA

Explore the linked device profile

Other records with product code MJO

Product / regulatory recordCompanyPathwayDecision dateSource
Spineart USA, Inc.PMA supplementSep 22, 2026FDA
Highridge Medical, LLCPMA supplementSep 16, 2026FDA
Highridge Medical, LLCPMA supplementSep 16, 2026FDA
prodisc C NovaP070001/S031
Centinel Spine, LLCPMA supplementSep 9, 2026FDA
Spineart USA, Inc.PMA approvalAug 10, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

FDA describes the real-time supplement process as a review route for minor changes to a device, including certain design, software, sterilization or labeling changes.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Synergy Spine Solutions, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
357 S. Mccaslin Blvd., Suite 120, Louisville, CO, 80027

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records